Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:NM)

N/A UNCHANGED
Last Price Updated: 9:49 AM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NM

< Previous 1 2 Next >
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... 
From Novamind Inc.
Via AccessWire
Topics Death
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... 
From Novamind Inc.
Via AccessWire
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc.... 
From Novamind Inc.
Via AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
- Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of... 
From Novamind Inc.
Via AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc
Via AccessWire
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... 
From Novamind Ventures Inc.
Via AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced... 
From Novamind Inc.
Via AccessWire
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... 
From Novamind Inc.
Via AccessWire
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces... 
From Novamind Inc.
Via AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
- Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations­­ - Expanded network to six clinics and three clinical research sites - Contracted for eight... 
From Novamind Inc.
Via AccessWire
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased... 
From Novamind Ventures Inc.
Via AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... 
From Novamind Inc.
Via AccessWire
Novamind to Present at LD Micro and KCSA Conferences
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Novamind Launches New Psychedelic Palliative Care Program
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc.... 
From Novamind Inc.
Via AccessWire
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"... 
From Novamind Ventures Inc.
Via AccessWire
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
TORONTO, ON / ACCESSWIRE / September 30, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Inc.
Via AccessWire
Novamind Announces DTC Eligibility for its Common Shares
TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Inc.
Via AccessWire
Novamind to Present at Benzinga Healthcare Conference
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare TORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc.... 
From Novamind Inc.
Via AccessWire
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Inc.
Via AccessWire
Novamind to Present at Life Sciences Investor Forum
TORONTO, ON / ACCESSWIRE / September 14, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Inc.
Via AccessWire
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
Cedar Clinical Research to Host Phase III Trial for Investigational Therapy for Schizophrenia TORONTO, ON / ACCESSWIRE / September 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... 
From Novamind Inc.
Via AccessWire
Novamind Uplists to OTCQB Venture Market
TORONTO, ON / ACCESSWIRE / September 9, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Ventures Inc.
Via AccessWire
Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
TORONTO, ON / ACCESSWIRE / September 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... 
From Novamind Inc.
Via AccessWire
Novamind Divests Non-Core Retreat Investment
TORONTO, ON / ACCESSWIRE / August 11, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Novamind Strengthens Mental Health Expertise, Adds Communications Leader
Samantha DeLenardo joins from CAMH, Canada's largest mental health teaching hospital and leader in mental health research TORONTO, ON / ACCESSWIRE / August 6, 2021 / Novamind Inc., (CSE:NM)(OTC... 
From Novamind Inc.
Via AccessWire
Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions
Company executes organic growth mandate, on track to open four new clinics by Q3 2021 TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the... 
From Novamind Inc.
Via AccessWire
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
Aims to increase visibility and facilitate investment for United States investors TORONTO, ON / ACCESSWIRE / July 21, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the... 
From Novamind Inc.
Via AccessWire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.